Scarica l'app Stockscreener
3.08
6.67%
-0.22
Pre-mercato:
3.07
-0.01
-0.32%
Precedente Chiudi:
$3.30
Aprire:
$3.22
Volume 24 ore:
101.48K
Relative Volume:
0.03
Capitalizzazione di mercato:
$2.89M
Reddito:
-
Utile/perdita netta:
$-12.88M
Rapporto P/E:
-0.0864
EPS:
-35.6417
Flusso di cassa netto:
$-8.79M
1 W Prestazione:
-13.73%
1M Prestazione:
-56.25%
6M Prestazione:
-47.08%
1 anno Prestazione:
-83.70%
Intervallo 1D:
$3.05
$3.23
Intervallo di 1 settimana:
$3.05
$3.5995
Portata 52W:
$2.955
$85.80
Artelo Biosciences Inc Stock (ARTL) Company Profile
Nome
Artelo Biosciences Inc
Settore
Industria
Telefono
858-925-7049
Indirizzo
505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH, CA
Compare ARTL vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ARTL
Artelo Biosciences Inc
|
3.08 | 2.89M | 0 | -12.88M | -8.79M | -35.64 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Artelo Biosciences Inc Stock (ARTL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-08 | Aggiornamento | D. Boral Capital | Hold → Buy |
| 2021-02-12 | Iniziato | Ladenburg Thalmann | Buy |
Artelo Biosciences Inc Borsa (ARTL) Ultime notizie
Artelo Biosciences | S-3: Registration statement for specified transactions by certain issuers - Moomoo
Artelo Biosciences may offer securities up to $75 millionSEC filing - marketscreener.com
Artelo Biosciences (NASDAQ: ARTL) files $75M shelf, includes $69.29M unsold - Stock Titan
What's behind the rise in Artelo Biosciences stock? - MSN
Why did ARTL stock skyrocket over 141% pre-market today? - MSN
Avis Budget Group, Toyota Motor and other big stocks moving lower in Monday's pre-market session - MSN
Artelo Biosciences (ARTL) Partners with ScienceMachine for AI-Dr - GuruFocus
Artelo Biosciences Announces Strategic Collaboration with Artificial Intelligence (AI) Leader ScienceMachine Highlighting New Expansion Opportunities and Insights for FABP5 Inhibitor Development - The Manila Times
Artelo Biosciences Announces Strategic Collaboration with Artificial Intelligence Leader Sciencemachine Highlighting New Expansion Opportunities and Insights for FABP5 Inhibitor Development - marketscreener.com
Why is ARTL stock soaring pre-market today? - MSN
ARTL Stock Chart | ARTELO BIOSCIENCES INC (NASDAQ:ARTL) - ChartMill
Artelo Biosciences stock soars after withdrawing SEC filing - MSN
Artelo (ARTL) Stock Fundamentals | Q4 2025: EPS Exceeds ExpectationsRetail Trader Ideas - Cổng thông tin điện tử tỉnh Tây Ninh
ARTL (Artelo Biosciences Inc.) delivers 97.5 percent positive Q4 2025 EPS surprise, but shares drop 8.64 percent today. - Cổng thông tin điện tử tỉnh Tây Ninh
What's Behind The Rise In Artelo Biosciences Stock? - Sahm
Artelo Biosciences (ARTL) Publishes Insightful Research on Pain Management - GuruFocus
Artelo (ARTL) Stock Short Interest Analysis (Smart Money Flows) 2026-04-20Community Momentum Stocks - Cổng thông tin điện tử tỉnh Lào Cai
ARTL Stock In Play As Pipeline Expands And Nasdaq Risk Eases - StocksToTrade
ARTL Stock Draws Traders As Biotech Pipeline Expands - timothysykes.com
Artelo Biosciences jumps after Nasdaq compliance update, with low-float volatility likely adding fuel - Quiver Quantitative
ARTL Stock Whipsaws As Artelo Biosciences Expands High-Risk, High-Reward Pipeline - timothysykes.com
Top movers in Monday's pre-market session - ChartMill
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Artelo Biosciences Highlights Promising Efficacy and Safety Profile of ART26.12 as a Novel Pain Treatment Ahead of Upcoming Clinical Studies - Quiver Quantitative
Artelo says non-opioid pain drug had no serious drug-related events - Stock Titan
Artelo Biosciences Inc (ARTLW) - Minichart
Artelo Biosciences (NASDAQ: ARTL) registers 9.82M shares for resale, warrants included - Stock Titan
[EFFECT] ARTELO BIOSCIENCES, INC. SEC Filing - Stock Titan
Artelo Biosciences Stock Short Interest Rises to 64.32% - Quiver Quantitative
ARTL Should I Buy - Intellectia AI
12 Health Care Stocks Moving In Tuesday's After-Market Session - Sahm
Aug Wrap: What is the cash position of Artelo Biosciences Inc2026 Setups & Daily Market Momentum Tracking - baoquankhu1.vn
Panic Selling: What is the cash position of Artelo Biosciences IncQuarterly Performance Summary & Weekly Setup with ROI Potential - baoquankhu1.vn
Artelo Biosciences regains Nasdaq listing compliance By Investing.com - Investing.com Australia
Artelo Biosciences Files Offering for 9.8 Million Common Stock; Shares Tumble - marketscreener.com
9.8M Artelo Biosciences (ARTL) shares registered for resale after March 2026 PIPE - Stock Titan
Artelo Biosciences Regains Compliance With Nasdaq Listing Requirements - Moomoo
Artelo Biosciences regains Nasdaq listing compliance - Investing.com
Artelo Biosciences Regains Nasdaq Compliance and Advances Clinical Pipeline for Cancer and Pain Treatments - Minichart
Why Is ARTL Stock Soaring Pre-Market Today? - Stocktwits
Artelo Biosciences Regains Compliance with Nasdaq Listing Requirements - The Manila Times
Artelo Biosciences regains Nasdaq compliance, subject to one-year panel monitor - TradingView — Track All Markets
Artelo Biosciences (NASDAQ: ARTL) regains full Nasdaq listing compliance - Stock Titan
Artelo Biosciences Inc Azioni (ARTL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.14%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):